180 related articles for article (PubMed ID: 11865091)
1. Fluoride and strontium accumulation in bone does not correlate with osteoid tissue in dialysis patients.
Cohen-Solal ME; Augry F; Mauras Y; Morieux C; Allain P; de Vernejoul MC
Nephrol Dial Transplant; 2002 Mar; 17(3):449-54. PubMed ID: 11865091
[TBL] [Abstract][Full Text] [Related]
2. [Effect of strontium on bone metabolism in hemodialysis patients].
Gerstenfeld S; Hinojosa L; Serrano Arias M; Menéndez Rodríguez P; Fernández Martín JL; Marchante JM; García Alonso JI; Sanz-Medel A; Cannata Andía JB
Nefrologia; 2003; 23 Suppl 2():52-6. PubMed ID: 12778855
[TBL] [Abstract][Full Text] [Related]
3. Increased bone strontium levels in hemodialysis patients with osteomalacia.
D'Haese PC; Schrooten I; Goodman WG; Cabrera WE; Lamberts LV; Elseviers MM; Couttenye MM; De Broe ME
Kidney Int; 2000 Mar; 57(3):1107-14. PubMed ID: 10720963
[TBL] [Abstract][Full Text] [Related]
4. Histomorphometric assessment of bone turnover in uraemic patients: comparison between activation frequency and bone formation rate.
Ballanti P; Coen G; Mazzaferro S; Taggi F; Giustini M; Calabria S; Ferrannini M; Bonucci E
Histopathology; 2001 Jun; 38(6):571-83. PubMed ID: 11422502
[TBL] [Abstract][Full Text] [Related]
5. The localization of aluminium and other elements in bone tissue of a case of renal osteodystrophy with an associated dialysis encephalopathy syndrome.
McClure J; Smith PS
J Pathol; 1984 Apr; 142(4):293-9. PubMed ID: 6716213
[TBL] [Abstract][Full Text] [Related]
6. Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study.
Charhon SA; Chavassieux P; Boivin G; Parisien M; Chapuy MC; Traeger J; Meunier PJ
Clin Sci (Lond); 1987 Aug; 73(2):227-34. PubMed ID: 3652627
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent effects of strontium on bone of chronic renal failure rats.
Schrooten I; Behets GJ; Cabrera WE; Vercauteren SR; Lamberts LV; Verberckmoes SC; Bervoets AJ; Dams G; Goodman WG; De Broe ME; D'Haese PC
Kidney Int; 2003 Mar; 63(3):927-35. PubMed ID: 12631073
[TBL] [Abstract][Full Text] [Related]
8. Low bone turnover in patients with renal failure.
Couttenye MM; D'Haese PC; Verschoren WJ; Behets GJ; Schrooten I; De Broe ME
Kidney Int Suppl; 1999 Dec; 73():S70-6. PubMed ID: 10633468
[TBL] [Abstract][Full Text] [Related]
9. Iron overload and bone disease in chronic dialysis patients.
Van de Vyver FL; Visser WJ; D'Haese PC; De Broe ME
Nephrol Dial Transplant; 1990; 5(9):781-7. PubMed ID: 2129351
[TBL] [Abstract][Full Text] [Related]
10. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
Jarava C; Armas JR; Palma A
Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
[TBL] [Abstract][Full Text] [Related]
11. Fluoride metabolism and renal osteodystrophy in regular dialysis treatment.
Erben J; Hájaková B; Pantůcek M; Kubes L
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():421-5. PubMed ID: 3991535
[TBL] [Abstract][Full Text] [Related]
12. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study.
Coen G; Mazzaferro S; Ballanti P; Sardella D; Chicca S; Manni M; Bonucci E; Taggi F
Nephrol Dial Transplant; 1996 May; 11(5):813-9. PubMed ID: 8671900
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis.
Spasovski GB; Bervoets AR; Behets GJ; Ivanovski N; Sikole A; Dams G; Couttenye MM; De Broe ME; D'Haese PC
Nephrol Dial Transplant; 2003 Jun; 18(6):1159-66. PubMed ID: 12748350
[TBL] [Abstract][Full Text] [Related]
14. [Renal osteodystrophy (3); its treatment in dialysis patients].
Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
[TBL] [Abstract][Full Text] [Related]
15. Strontium overload and toxicity: impact on renal osteodystrophy.
Cohen-Solal M
Nephrol Dial Transplant; 2002; 17 Suppl 2():30-4. PubMed ID: 11904356
[TBL] [Abstract][Full Text] [Related]
16. Strontium causes osteomalacia in chronic renal failure rats.
Schrooten I; Cabrera W; Goodman WG; Dauwe S; Lamberts LV; Marynissen R; Dorriné W; De Broe ME; D'Haese PC
Kidney Int; 1998 Aug; 54(2):448-56. PubMed ID: 9690211
[TBL] [Abstract][Full Text] [Related]
17. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E
Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392
[TBL] [Abstract][Full Text] [Related]
18. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
[TBL] [Abstract][Full Text] [Related]
19. [Renal osteodystrophy: aluminium and secondary hyperparathyroidism].
de Vernejoul MC
Rev Prat; 1990 Mar; 40(7):613-8. PubMed ID: 2326587
[TBL] [Abstract][Full Text] [Related]
20. Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects.
Lundy MW; Stauffer M; Wergedal JE; Baylink DJ; Featherstone JD; Hodgson SF; Riggs BL
Osteoporos Int; 1995 Mar; 5(2):115-29. PubMed ID: 7599448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
